Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 825
Filtrar
1.
WMJ ; 121(3): E60-E62, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36301662

RESUMEN

INTRODUCTION: Agranulocytosis, a severe decrease or absence of neutrophils, is a side effect of several medications, including chlorpromazine. If not promptly recognized, it can lead to overwhelming infection, sepsis, and death. CASE PRESENTATION: A 72-year-old man with adenocarcinoma of the lung status-post recent lobectomy was admitted for postsurgical pain and electrolyte derangement. During his admission, he had intractable hiccups and was started on chlorpromazine 25 mg by mouth 3 times a day. Within a week, he developed pneumonia, type 1 respiratory failure, and a progressive neutropenia. Chlorpromazine-induced agranulocytosis was suspected and chlorpromazine was discontinued; however, the patient expired, with postmortem findings of aspergillus bronchopneumonia as cause of death. DISCUSSION: Chlorpromazine is a well-studied cause of agranulocytosis. This case is novel in its rapid time course of less than 1 week; most cases report the resultant agranulocytosis on the order of weeks rather than days. CONCLUSION: This case highlights an important need to recognize this medication side effect early so the offending agent may be stopped and the patient properly supported, so as to avoid the severe risk of neutropenic infection, sepsis, and death.


Asunto(s)
Agranulocitosis , Hipo , Sepsis , Masculino , Humanos , Anciano , Clorpromazina/efectos adversos , Hipo/tratamiento farmacológico , Hipo/etiología , Agranulocitosis/inducido químicamente , Agranulocitosis/complicaciones , Agranulocitosis/tratamiento farmacológico , Sepsis/tratamiento farmacológico
2.
Parasitology ; 148(1): 53-62, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33087186

RESUMEN

Susceptibility to Echinococcus multilocularis infection considerably varies among intermediate (mostly rodents) and dead-end host species (e.g. humans and pig), in particular regarding intestinal oncosphere invasion and subsequent hepatic metacestode development. Wistar rats are highly resistant to infection and subsequent diseases upon oral inoculation with E. multilocularis eggs, however, after immunosuppressive treatment with dexamethasone, rats become susceptible. To address the role of the cellular innate immunity, Wistar rats were individually or combined depleted of natural killer (NK) cells, macrophages (MΦ) and granulocytes (polymorphonuclear cells, PMN) prior to E. multilocularis egg inoculation. Although NK cell and MΦ depletion did not alter the resistance status of rats, the majority of PMN-depleted animals developed liver metacestodes within 10 weeks, indicating that PMN are key players in preventing oncosphere migration and/or development in Wistar rats. In vitro studies indicated that resistance is not caused by neutrophil reactive oxygen species or NETosis. Also, light microscopical examinations of the small intestine showed that oral inoculation of E. multilocularis eggs does not elicit a mucosal neutrophil response, suggesting that the interaction of oncospheres and neutrophils may occur after the former have entered the peripheral blood. We suggest to consider granulocytes as mediators of resistance in more resistant species, such as humans.


Asunto(s)
Agranulocitosis/complicaciones , Equinococosis Hepática/inmunología , Echinococcus multilocularis , Inmunidad Innata , Animales , Modelos Animales de Enfermedad , Resistencia a la Enfermedad , Susceptibilidad a Enfermedades/inducido químicamente , Equinococosis/inmunología , Echinococcus multilocularis/crecimiento & desarrollo , Echinococcus multilocularis/inmunología , Granulocitos/inmunología , Inmunidad Mucosa , Inmunosupresores/administración & dosificación , Intestinos/inmunología , Intestinos/parasitología , Células Asesinas Naturales/inmunología , Hígado/parasitología , Macrófagos/inmunología , Neutrófilos/inmunología , Ratas , Ratas Wistar/parasitología
4.
Rev. cuba. invest. bioméd ; 39(2): e498, abr.-jun. 2020.
Artículo en Español | LILACS, CUMED | ID: biblio-1126592

RESUMEN

Se estudió una paciente de 33 años de edad con antecedentes patológicos de Bocio tiroideo difuso desde hace 8 años, que acude al cuerpo de guardia por presentar falta de aire, fiebre de 39-40 °C, dolor de garganta y palpitaciones hace alrededor de tres días. Al examen físico se le constató exoftalmos, mucosas hipocoloreadas y faringe purulenta y punteada de color blanquecina, artralgia y taquicardia. Referente a los exámenes complementarios presentó anemia, leucopenia y pancitopenia luego de haber consumido propiltiouracilo (50mg) por un período prolongado; por lo que se concluye como agranulocitosis como consecuencia de una reacción adversa al propiltiouracilo. Luego de ser tratada la paciente se recupera de su gravedad con el uso de factores estimulantes de colonias de granulocitos(AU)


A female 33-year-old patient with an 8-year history of diffuse thyroid goiter presents at the emergency service with shortness of breath, a 39-40ºC fever, a sore throat and palpitation of 3 days' evolution. Physical examination revealed exophthalmos, hypopigmented mucosas, a purulent pharynx dotted with whitish spots, arthralgia and tachycardia. Complementary tests found anemia, leukopenia and pancytopenia upon consumption of propylthiouracil (50 mg) for a long period. The diagnosis is agranulocytosis resulting from an adverse reaction to propylthiouracil. After being treated the patient recovered from her severe status with the use of granulocyte colony stimulating factors(AU)


Asunto(s)
Humanos , Femenino , Adulto , Propiltiouracilo/efectos adversos , Agranulocitosis/complicaciones , Bocio
5.
Mycoses ; 63(7): 653-682, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32236989

RESUMEN

BACKGROUND: Invasive fungal diseases remain a major cause of morbidity and mortality in cancer patients undergoing intensive cytotoxic therapy. The choice of the most appropriate antifungal treatment (AFT) depends on the fungal species suspected or identified, the patient's risk factors (eg length and depth of granulocytopenia) and the expected side effects. OBJECTIVES: Since the last edition of recommendations for 'Treatment of invasive fungal infections in cancer patients' of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) in 2013, treatment strategies were gradually moving away from solely empirical therapy of presumed or possible invasive fungal diseases (IFDs) towards pre-emptive therapy of probable IFD. METHODS: The guideline was prepared by German clinical experts for infections in cancer patients in a stepwise consensus process. MEDLINE was systematically searched for English-language publications from January 1975 up to September 2019 using the key terms such as 'invasive fungal infection' and/or 'invasive fungal disease' and at least one of the following: antifungal agents, cancer, haematological malignancy, antifungal therapy, neutropenia, granulocytopenia, mycoses, aspergillosis, candidosis and mucormycosis. RESULTS: AFT of IFDs in cancer patients may include not only antifungal agents but also non-pharmacologic treatment. In addition, the armamentarium of antifungals for treatment of IFDs has been broadened (eg licensing of isavuconazole). Additional antifungals are currently under investigation or in clinical trials. CONCLUSIONS: Here, updated recommendations for the treatment of proven or probable IFDs are given. All recommendations including the levels of evidence are summarised in tables to give the reader rapid access to key information.


Asunto(s)
Antifúngicos/uso terapéutico , Neoplasias Hematológicas/tratamiento farmacológico , Hematología/organización & administración , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Neoplasias/complicaciones , Guías de Práctica Clínica como Asunto , Agranulocitosis/complicaciones , Agranulocitosis/microbiología , Neoplasias Hematológicas/complicaciones , Hematología/métodos , Humanos , Huésped Inmunocomprometido , Infecciones Fúngicas Invasoras/etiología , Neoplasias/microbiología
6.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(2): 669-676, 2020 Apr.
Artículo en Chino | MEDLINE | ID: mdl-32319414

RESUMEN

OBJECTIVE: To explore the clinical features and risk factors for nosocomial infections in agranulocytosis patients with hematological malignancies so as to provide basis for clinical prevention and treatment of nosocomial infections. METHODS: The clinical data of 725 patients with agranulocytosis in the First Hospital of Lanzhou University from May 2015 to May 2018 were retrospectively analyzed, including sex, age, primary disease, treatment stage, agranulocytosis degree, agranulocytosis duration, nosocomial infection, infectous site, average length of stay and average days of infection. Univariate analysis (Chi-square test) and multivariate analysis (non-conditional Logistic regression models) were used to analyze the risk factors of nosocomial infection. RESULTS: The most common sites of nosocomial infection in agranulocytosis patients with hematological maliguancies were upper respiratory tract, accounting for 24.0%, followed by lung (16.2%) and blood stream (13.8%). In disease composition, acute leukemia holded the first place, accounting for 82.1%, among which the acute myeloid leukemia had the highest infection rate, accounting for 73.3%, followed by acute lymphoblastic leukemia. The infection rates were 68.0% and 66.7% for multiple myeloma, 79.3% and 84.5% for acute leukemia at the initial induction and relapse stages, respectively. 184 pathogenic bacteria were isolated clinically, of which 126 were a Gram-negative bacteria, 23 were Gram-positive bacteria and 35 were fungi, accounting for 68.48%, 12.50% and 19.02%, respectively. It was found that age, primary disease, degree and duration of granulocyte deficiency, chemotherapy, glucocorticoid use and disease status all associated with nosocomial infection (P<0.05). Multivariate unconditional logistic regression analysis showed that acute leukemia, absolute count of neutrophils<0.2×109/L, chemotherapy and disease unremitting were the main risk factors of nosocomial infection. CONCLUSION: The patients with malignant hematological agranulocytosis are a high-risk population of nosocomial infection. Nosocomial infection rate is still high, especially in patients with acute leukemia who have received chemotherapy or without complete remission or neutrophil absolute count less than 0.2×109/L. Thus early intervention measures should be taken to reduce the incidence of nosocomial infection and mortality.


Asunto(s)
Agranulocitosis , Infección Hospitalaria , Neoplasias Hematológicas , Agranulocitosis/complicaciones , Neoplasias Hematológicas/complicaciones , Humanos , Estudios Retrospectivos , Factores de Riesgo
7.
Asia Pac J Clin Nutr ; 28(4): 711-719, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31826367

RESUMEN

BACKGROUND AND OBJECTIVES: The optimal timing for initiating supplemental parenteral nutrition in chemotherapy- induced severe granulocytopenia in patients with lung cancer remains uncertain. METHODS AND STUDY DESIGN: A retrospective study was conducted among patients with lung cancer from February 2016 to June 2018. In total, 182 eligible patients were included and divided into 2 groups according to the time of supplemental parenteral nutrition intervention: early initiation (within 72 hours of development of granulocytopenia) and late initiation (over 72 hours). The primary outcomes of the study were bacterial infection and fungal infection, and the secondary outcomes were duration of absolute neutrophil count less than 1.0×109 cells/L, length of hospital stay, mortality rate, and rate of chemotherapy (4 cycles) completion. RESULTS: The incidence rates of bacterial infection and fungal infection were significantly lower among patients who received supplemental parenteral nutrition early than among patients who received it late. No significant difference in mortality was observed between the groups. In addition, compared with late supplemental parenteral nutrition, early supplemental parenteral nutrition was associated with a higher rate of completion of 4 chemotherapy cycles and shorter hospital stays and leukocyte recovery periods in our cohort. Univariate and multivariate logistic regression analyses revealed that the subgroup of patients with an NRS-2002 score of 2 benefited from early supplemental parenteral nutrition. CONCLUSIONS: Early supplemental parenteral nutrition after chemotherapy-induced severe granulocytopenia could reduce the risk of infection, improve the likelihood of chemotherapy completion, and shorten hospital stays and leukocyte recovery times.


Asunto(s)
Agranulocitosis/complicaciones , Antineoplásicos/efectos adversos , Infecciones Bacterianas/prevención & control , Neoplasias Pulmonares/complicaciones , Nutrición Parenteral , Anciano , Infecciones Bacterianas/etiología , Estudios de Cohortes , Ingestión de Energía , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo
8.
Am J Case Rep ; 19: 630-633, 2018 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-29853712

RESUMEN

BACKGROUND Levamisole is a common adulterant of cocaine and up to 69% of seized cocaine in United States contains levamisole. It is a synthetic imidazothiazole derivative which was previously used as an immunomodulating agent for treatment of various connective tissue disorders and colorectal carcinoma. However, it was withdrawn later from the market due to significant toxicity associated with it. CASE REPORT We present the case of a 59-year-old male patient with a history of active cocaine use who presented to the hospital with febrile neutropenia and agranulocytosis. He underwent extensive work-up for neutropenia and was suspected to have it secondary to levamisole-adulterated cocaine. He was treated with antibiotics and granulocyte-stimulating factor. His white cell count improved and he was discharged home. He continued to use cocaine after discharge from the hospital. He returned to the hospital 3 weeks later with recurrent neutropenia and agranulocytosis complicated by septic shock and bowel necrosis which required prolonged antibiotics and a bowel resection. CONCLUSIONS Levamisole-induced agranulocytosis should be considered in patients who present with neutropenia and a history of cocaine use. Physicians should have high clinical suspicion and consider it a potential etiology of agranulocytosis when other causes have been excluded.


Asunto(s)
Adyuvantes Inmunológicos/efectos adversos , Agranulocitosis/inducido químicamente , Trastornos Relacionados con Cocaína/complicaciones , Intestinos/irrigación sanguínea , Isquemia/complicaciones , Levamisol/efectos adversos , Agranulocitosis/complicaciones , Agranulocitosis/terapia , Contaminación de Medicamentos , Humanos , Intestinos/patología , Isquemia/cirugía , Masculino , Persona de Mediana Edad , Necrosis/patología , Necrosis/cirugía , Necrosis/terapia , Recurrencia , Choque Séptico/complicaciones , Choque Séptico/terapia
9.
J Infect Chemother ; 23(11): 785-787, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28729050

RESUMEN

Streptococcus pneumoniae is a main causative agent of serious invasive bacterial infections. However, concurrent infection with invasive pneumococcal disease (IPD) and viral infectious mononucleosis (IM) is rare. We report an infant with serotype 6C infection causing IPD occurring simultaneously with IM. A previously healthy 11-month-old girl referred to our hospital because of fever, leukopenia, and elevated C-reactive protein presented to us with disturbance of consciousness, tachycardia, tachypnea and agranulocytosis. Other findings included tonsillitis with purulent exudates and white spots, bilateral cervical adenopathy, and hepatosplenomegaly. We diagnosed her illness as sepsis and administered a broad-spectrum antibiotic, an antiviral agent, and granulocyte transfusions. After treatment was initiated, fever gradually decreased and general condition improved. IPD was diagnosed based upon isolation of S. pneumoniae of serotype 6C from blood cultures obtained on admission. Concurrently the girl had IM, based upon quantitation of Epstein-Barr viral DNA copies in blood and fluctuating serum antibody titers. Although simultaneous IPD and IM is a rare occurrence, this possibility is important to keep in mind.


Asunto(s)
Agranulocitosis/complicaciones , Fiebre/complicaciones , Mononucleosis Infecciosa/complicaciones , Infecciones Neumocócicas/complicaciones , Streptococcus pneumoniae/aislamiento & purificación , Agranulocitosis/sangre , Agranulocitosis/microbiología , Agranulocitosis/terapia , Antibacterianos/uso terapéutico , Proteína C-Reactiva/análisis , Citomegalovirus/aislamiento & purificación , Femenino , Fiebre/sangre , Fiebre/tratamiento farmacológico , Fiebre/microbiología , Vacuna Neumocócica Conjugada Heptavalente/administración & dosificación , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Lactante , Mononucleosis Infecciosa/sangre , Mononucleosis Infecciosa/microbiología , Mononucleosis Infecciosa/terapia , Transfusión de Leucocitos , Infecciones Neumocócicas/sangre , Infecciones Neumocócicas/microbiología , Infecciones Neumocócicas/terapia , Reacción en Cadena de la Polimerasa , Serogrupo , Serotipificación , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pneumoniae/inmunología
10.
Arch Pediatr ; 24(8): 752-756, 2017 Aug.
Artículo en Francés | MEDLINE | ID: mdl-28669649

RESUMEN

INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe toxidermia that can lead to death from multivisceral failure. We report a case of DRESS associated with febrile agranulocytosis in a child. OBSERVATION: An 8-year-old child was hospitalized for diffuse maculopapular exanthema with edema of the extremities and face associated with cheilitis and febrile agranulocytosis. This symptomatology began 1month after the introduction of carbamazepine for partial epilepsy. The clinical picture was a multisystemic disease with colitis, interstitial pneumonitis, hepatic cytolysis, and hepatocellular insufficiency. HHV7 viral reactivation and increased eosinophils (20%) in the myelogram were demonstrated, providing the diagnosis of DRESS. The progression was favorable after carbamazepine therapy was stopped and systemic corticosteroids were administered. DISCUSSION: DRESS syndrome is a disorder that is unfamiliar to pediatricians. Its association with agranulocytosis is rare and the absence of hypereosinophilia contributed to diagnostic difficulties in this case. The multisystemic failure, the reactivation of HHV7, the increase of eosinophils in the myelogram, and the favorable progression under systemic corticosteroid therapy contributed greatly to the diagnosis. A cutaneous biopsy was not considered necessary for the diagnosis in the case reported herein. CONCLUSION: DRESS syndrome is rarely associated with agranulocytosis, but its diagnosis must be quickly raised so that the incriminated drug can be interrupted.


Asunto(s)
Agranulocitosis/complicaciones , Anticonvulsivantes/efectos adversos , Carbamazepina/efectos adversos , Síndrome de Hipersensibilidad a Medicamentos/tratamiento farmacológico , Síndrome de Hipersensibilidad a Medicamentos/etiología , Glucocorticoides/uso terapéutico , Agranulocitosis/diagnóstico , Agranulocitosis/tratamiento farmacológico , Anticonvulsivantes/administración & dosificación , Carbamazepina/administración & dosificación , Niño , Síndrome de Hipersensibilidad a Medicamentos/diagnóstico , Epilepsias Parciales/tratamiento farmacológico , Fiebre/etiología , Humanos , Resultado del Tratamiento
11.
Internist (Berl) ; 58(7): 740-744, 2017 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-28265684

RESUMEN

We report on a 77-year-old male patient with neutropenic fever as a result of a newly diagnosed agranulocytosis. The patient was taking metamizole, which is a well known cause of agranulocytosis. The diagnosis of metamizole-induced agranulocytosis as an underestimated side-effect of metamizole could be confirmed by a bone marrow biopsy. The bone marrow and the blood count recovered completely after stopping the therapy with metamizole and administration of granulocyte colony-stimulating factor (G-CSF).


Asunto(s)
Agranulocitosis/complicaciones , Neutropenia Febril/etiología , Factor Estimulante de Colonias de Granulocitos/uso terapéutico , Anciano , Agranulocitosis/inducido químicamente , Agranulocitosis/tratamiento farmacológico , Antiinflamatorios no Esteroideos/efectos adversos , Dipirona/efectos adversos , Humanos , Masculino
12.
Curr Hematol Malig Rep ; 12(1): 29-38, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-28197963

RESUMEN

Chronic lymphocytic leukemia (CLL) is frequently associated with autoimmune complications such as autoimmune hemolytic anemia, immune thrombocytopenia, pure red cell aplasia, and autoimmune granulocytopenia. It is critical to diagnose cytopenias from these secondary complications of CLL accurately, since prognosis and therapy are substantially different from patients who have cytopenias due to extensive bone marrow infiltration by CLL. The pathogenesis of autoimmune cytopenias in CLL is complex; and it involves antigen presentation by CLL cells to polyclonal B cells resulting in production of autoantibody, and alteration of the T cell milieu tilting the balance in favor of an autoimmune response. Traditional therapy of autoimmune complications in CLL consists of immunosuppression with corticosteroids and/or anti-CD20 monoclonal antibodies. In patients who have a suboptimal response, treating the underlying CLL is generally effective in ameliorating secondary cytopenias. Although novel oral therapies such as ibrutinib, idelalisib, and venetoclax have been shown to be extremely effective in the management of CLL, prospective data from larger numbers of patients with longer follow-up are needed prior to recommending their routine use in the management of autoimmune cytopenias in CLL.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Leucemia Linfocítica Crónica de Células B/patología , Agranulocitosis/complicaciones , Agranulocitosis/tratamiento farmacológico , Agranulocitosis/epidemiología , Anemia Hemolítica Autoinmune/complicaciones , Anemia Hemolítica Autoinmune/diagnóstico , Anemia Hemolítica Autoinmune/tratamiento farmacológico , Anemia Hemolítica Autoinmune/epidemiología , Humanos , Inmunosupresores/uso terapéutico , Leucemia Linfocítica Crónica de Células B/complicaciones , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/uso terapéutico , Aplasia Pura de Células Rojas/complicaciones , Aplasia Pura de Células Rojas/tratamiento farmacológico , Aplasia Pura de Células Rojas/epidemiología , Rituximab/administración & dosificación , Trombocitopenia/complicaciones , Trombocitopenia/tratamiento farmacológico , Trombocitopenia/epidemiología
13.
Medicine (Baltimore) ; 95(52): e5717, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28033275

RESUMEN

RATIONALE: Pregnancy is a complicated physiological process. Physiological leukocytosis often takes place and it is primarily related to the increased circulation of neutrophils, especially during the last trimester of pregnancy. Noncongenital agranulocytosis during pregnancy is rare and reported only occasionally, while in most of the cases, the agranulocytosis has already occurred prior to pregnancy or induced by identified factors such as antibiotics, antithyroid agents, or cytotoxic agents. Gestation-induced agranulocytosis has not been reported, so we present a case of gestation-induced agranulocytosis in this article. PATIENTS CONCERN: In this case, we present a Chinese woman (aged 25) in her 38th week of the first gestation who had the complication of agranulocytosis. No abnormality was detected in regular examinations before pregnancy and in the first trimester. Since the last trimester of pregnancy, the patient began to suffer from agranulocytosis and intermittent fever, the maximum being temperature 38.8°C. At admission, the neutrophil granulocytes were 0.17 × 10 L and the bone marrow biopsy showed that agranulocytosis was detected, but the levels of red blood cell and megalokaryocyte were normal. In addition, antinuclear antibodies were detected at a dilution of 1:40, but anti-dsDNA, antiphospholipid antibody, and neutrophil granulocyte antibody were negative. DIAGNOSES: The patient was empirically treated as having pneumonia. INTERVENTIONS: We tried to use granulocyte colony-stimulating factor, γ-globulin, glucocorticoids, antibiotics, and antifungi agents to treat the patient, but her symptoms were not alleviated until the patient had a cesarean section. OUTCOMES: After 24 hours of cesarean section, the temperature and neutrophil granulocyte returned to normal. After a year of follow-up, we found that the patient and the baby were healthy. LESSONS: Agranulocytosis during pregnancy seems to be associated with immunosuppression induced by immunoregulations and termination of pregnancy may be effective for refractory pregnancy complicated with agranulocytosis, but further studies are needed to confirm this.


Asunto(s)
Agranulocitosis/complicaciones , Complicaciones Hematológicas del Embarazo/diagnóstico , Adulto , Agranulocitosis/fisiopatología , Antibacterianos/uso terapéutico , Cesárea , Femenino , Fiebre/complicaciones , Humanos , Embarazo , Complicaciones Hematológicas del Embarazo/fisiopatología
14.
Ter Arkh ; 88(7): 72-77, 2016.
Artículo en Ruso | MEDLINE | ID: mdl-27459618

RESUMEN

AIM: to identify poor prognostic factors for perianal infection (PI) in patients with hemoblastosis and to define an effective tactic for preventive and therapeutic measures. SUBJECTS AND METHODS: The prospective study enrolled 72 patients (37 men and 35 women; mean age, 47 years) with hemoblastosis that was complicated by the development of one of the following forms of PI: abscess, infiltrate, multiple ulcers. Different clinical and laboratory characteristics of the patients were examined to identify risk factors for PI. The species-specific concordance of microorganisms isolated from the anus and blood in the development of PI was assessed to record the latter as a source of sepsis. Treatment policy was defined according to the clinical form of PI. RESULTS: Acute myeloid leukemias and lymphomas were the most common background diseases in 30 (41.7%) and 22 (30.6%) patients, respectively. During induction chemotherapy cycles, perianal tissue infection occurred twice more frequently (66%) than totally at the onset of hemoblastosis (13%) and after achievement of remission (during consolidation and maintenance therapy) (21%; Fisher's exact test; p=0.01). PI in agranulocytosis was more than twice as common as in its absence: 69.4% vs 30.6% (p=0.01) and was responsible for sepsis in 9 (18%) of 50 patients. The main source of perianal tissue infection in patients with granulocytopenia was anal fissures and fistulas and ulcers of the anal canal: 44 (88%) cases of the 50 cases. In PI as an abscess, the average white blood cell count was 5 times higher (p=0.01) than that in PI as an infiltrate (or multiple ulcers): 6.6·109/l and 1.2·109 g/l. Abscess formation was observed in 16 (22.2%) patients and an indication for surgical drain. The inflammatory infiltrate was found to develop in 48 (66.7%) patients; multiple ulcers were seen in 8 (11.1%); in this group, parenteral antimicrobial therapy proved to be effective in 36 (78%) patients. 29 patients were operated on for anal fissures and fistulas at intercycle intervals. After continuing CT, PI recurrences were observed in 4 (9.1%) patients. In the operated versus medically treated patients, the risk of complications associated with abnormalities in the perianal area during continued CT was 5 times statistically significantly lower (odds ratio=0.2; 95% confidence interval 0.1 to 0.5; p=0.04; Cochran-Mantel test). CONCLUSION: Induction CT cycles, the status of granulocytopenia, and the presence of infection sources in the anal canal as an anal fissure, skin ulcerations, or a fistula should be considered as independent statistically significant prognostic risk factors for PI. The number of granulocytes determines the form of inflammation, the course of infection, and the chance of developing sepsis. The effective prevention encompassing surgical treatment for anal canal diseases reduces the risk of septic complications and the number of paraproctitis recurrences, contributing to the implementation of a planned CT program in patients with hemoblastosis.


Asunto(s)
Absceso/etiología , Agranulocitosis/complicaciones , Enfermedades del Ano/etiología , Leucemia Mieloide Aguda/complicaciones , Linfoma/complicaciones , Sepsis/etiología , Absceso/microbiología , Absceso/prevención & control , Adulto , Enfermedades del Ano/microbiología , Enfermedades del Ano/prevención & control , Femenino , Fisura Anal/etiología , Fisura Anal/microbiología , Fisura Anal/prevención & control , Humanos , Masculino , Persona de Mediana Edad , Fístula Rectal/etiología , Fístula Rectal/microbiología , Fístula Rectal/prevención & control , Factores de Riesgo , Sepsis/prevención & control
15.
Intern Med ; 55(5): 537-40, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26935379

RESUMEN

Good's syndrome is an immunodeficiency disease involving thymoma accompanied by hypogammaglobulinemia. We encountered a case of Good's syndrome accompanied by agranulocytosis that followed a rapid clinical course. A 72-year-old man visited our hospital with a two-week history of a sore throat. Candida albicans was detected in the pharynx, and hypogammaglobulinemia was detected in addition to granulocytopenia. The patient subsequently developed septic shock and followed a rapid clinical course which ended in death. Good's syndrome with agranulocytosis was diagnosed at autopsy. Good's syndrome accompanied by agranulocytosis can follow a rapid clinical course and some cases remain asymptomatic until old age. Its prompt treatment is crucial.


Asunto(s)
Agammaglobulinemia/inmunología , Agranulocitosis/patología , Síndromes de Inmunodeficiencia/patología , Timoma/patología , Neoplasias del Timo/patología , Anciano , Agranulocitosis/complicaciones , Agranulocitosis/tratamiento farmacológico , Agranulocitosis/inmunología , Autopsia , Resultado Fatal , Humanos , Síndromes de Inmunodeficiencia/complicaciones , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Masculino , Faringitis/etiología , Síndrome , Timoma/complicaciones , Timoma/tratamiento farmacológico , Timoma/inmunología , Neoplasias del Timo/complicaciones , Neoplasias del Timo/tratamiento farmacológico , Neoplasias del Timo/inmunología
16.
Mycopathologia ; 181(1-2): 131-5, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26346378

RESUMEN

Infections caused by Fusarium species are increasing in frequency among immunocompromised hosts, but urinary tract infection (UTI) due to Fusarium proliferatum has not been reported in the literature so far. We describe a case of UTI caused by F. proliferatum in a 47-year-old man who was diagnosed with rectal cancer and metastasis. He underwent radical resection of rectal carcinoma and local resection of hepatic metastases. After the first adjuvant chemotherapy, the patient presented the obvious high fever, severely diarrhea and progressive decline of the white blood cell count. The direct microscopic examination of fungi in urine was positive, and the fungal cultures showed white, cotton-like colony. After the DNA sequencing, it was identified as F. proliferatum. We gave the patient itraconazole and other antibiotics to fight the infection. A month later, the temperature dropped to normal and the results of the direct microscopic examination and culture of fungi in urine turn negative. The itraconazole is effective against F. proliferatum.


Asunto(s)
Agranulocitosis/complicaciones , Fusariosis/diagnóstico , Fusariosis/patología , Fusarium/aislamiento & purificación , Neoplasias del Recto/complicaciones , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/patología , Antifúngicos/administración & dosificación , ADN de Hongos/química , ADN de Hongos/genética , Fusariosis/microbiología , Fusarium/clasificación , Fusarium/genética , Humanos , Itraconazol/administración & dosificación , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/secundario , Neoplasias Hepáticas/cirugía , Microscopía , Neoplasias del Recto/tratamiento farmacológico , Neoplasias del Recto/cirugía , Análisis de Secuencia de ADN , Resultado del Tratamiento , Infecciones Urinarias/microbiología , Orina/microbiología
17.
Intern Med ; 53(18): 2149-52, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25224205

RESUMEN

A 33-year-old man who had recently undergone surgery for cervical spondylotic myelopathy was prescribed pregabalin for neuralgia, and the dose was increased to 600 mg/day during hospitalization. However, the patient was diagnosed with a Clostridium difficile infection on day 34 after admission. A complete blood count showed agranulocytosis (neutrophil count: 105/µL). We did not observe any changes in vital signs, a relative increase in band cells, or intestinal edema. The patient's agranulocytosis resolved after withdrawing pregabalin. This is the first reported case of agranulocytosis associated with pregabalin. Periodic monitoring of the white blood cell count is therefore considered to be useful in patients receiving high-dose pregabalin therapy.


Asunto(s)
Agranulocitosis/complicaciones , Clostridioides difficile/aislamiento & purificación , Infecciones por Clostridium/etiología , Ácido gamma-Aminobutírico/análogos & derivados , Adulto , Agranulocitosis/inducido químicamente , Infecciones por Clostridium/diagnóstico , Infecciones por Clostridium/microbiología , Humanos , Masculino , Pregabalina , Ácido gamma-Aminobutírico/efectos adversos
19.
Clin Dev Immunol ; 2013: 730131, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23690826

RESUMEN

The clinical course of chronic lymphocytic leukemia (CLL) may be complicated at any time by autoimmune phenomena.The most common ones are hematologic disorders, such as autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Pure red cell aplasia (PRCA) and autoimmune agranulocytosis (AG) are, indeed, more rarely seen. However, they are probably underestimated due to the possible misleading presence of cytopenias secondary to leukemic bone marrow involvement or to chemotherapy cytotoxicity. The source of autoantibodies is still uncertain, despite the most convincing data are in favor of the involvement of resting normal B-cells. In general, excluding the specific treatment of underlying CLL, the managementof these complications is not different from that of idiopathic autoimmune cytopenias or of those associated to other causes. Among different therapeutic approaches, monoclonal antibody rituximab, given alone or in combination, has shown to be very effective.


Asunto(s)
Agranulocitosis/inmunología , Anemia Hemolítica Autoinmune/inmunología , Leucemia Linfocítica Crónica de Células B/inmunología , Aplasia Pura de Células Rojas/inmunología , Trombocitopenia/inmunología , Agranulocitosis/complicaciones , Agranulocitosis/tratamiento farmacológico , Agranulocitosis/patología , Anemia Hemolítica Autoinmune/complicaciones , Anemia Hemolítica Autoinmune/tratamiento farmacológico , Anemia Hemolítica Autoinmune/patología , Anticuerpos Monoclonales de Origen Murino/uso terapéutico , Autoanticuerpos/inmunología , Autoinmunidad , Humanos , Factores Inmunológicos/uso terapéutico , Leucemia Linfocítica Crónica de Células B/complicaciones , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Leucemia Linfocítica Crónica de Células B/patología , Aplasia Pura de Células Rojas/complicaciones , Aplasia Pura de Células Rojas/tratamiento farmacológico , Aplasia Pura de Células Rojas/patología , Rituximab , Trombocitopenia/complicaciones , Trombocitopenia/tratamiento farmacológico , Trombocitopenia/patología
20.
Arch. méd. Camaguey ; 16(1): 83-90, ene.-feb. 2012.
Artículo en Español | LILACS | ID: lil-628113

RESUMEN

La mucormicosis es una infección oportunista, poco frecuente y potencialmente letal causada por hongos del orden mucorales. Pueden ser de varias formas: rinocerebral, (que es la más frecuente), pulmonar, cutánea, gastrointestinal, del sistema nervioso central y la miscelánea. Comienza habitualmente en las fosas nasales, senos paranasales o paladar.Caso clínico: paciente de 71 años de edad, de piel blanca, femenina que presentó la forma rinocerebral asociada a agranulocitosis más diabetes mellitus.Conclusiones: en la paciente se observaron lesiones localizadas en las fosas nasales, seno maxilar, etmoidal y órbita. Se demuestra que por su especificidad como método para el diagnóstico, el uso de la tomografía axial computarizada es de gran valor, lo que permite una correcta orientación terapéutica, junto a la debridación quirúrgica amplia de áreas anatómicas afectadas y el uso adecuado del anfotericina b así como el resto de los medicamentos, permitieron una evolución satisfactoria con una recuperación completa en un tiempo corto


Mucormycosis is an opportunist; rare, potentially lethal infection caused by fungi of the order of Mucolares. They may be of several forms: rhinocerebral, (which is the most common), pulmonary, cutaneous, gastrointestinal, central nervous system and miscellaneous. It usually begins in the nasal pits, paranasal sinuses, or palate.Case report: a white skin, female patient of 71 years old, who presented the rhinocerebral form associated with agranulocytosis and diabetes mellitus.Conclusions: the patient showed lesions in the nasal pits, maxillary and ethmoidal sinus, and orbit. It is demonstrated by its specificity as a diagnostic method, the great value of the computerized axial tomography, allowing a proper therapeutic orientation, with the comprehensive surgical procedure of the anatomical areas and the proper use of the amphotericin B as well as the rest of the drugs, enabled a satisfactory evolution with a total recovery in a short time


Asunto(s)
Humanos , Femenino , Anciano , Agranulocitosis/complicaciones , Diabetes Mellitus/complicaciones , Mucormicosis/complicaciones , Mucormicosis/diagnóstico , Tomografía Computarizada por Rayos X/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA